Leucadia National (LUK) Reports Q4 EPS from Cont. Ops. of $6.77
Leucadia National Corp. (NYSE: LUK) reports Q4 EPS from continuing operations of $6.77 on sales of $585.6 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) Plans to Spinoff Hemophilia Business into Independent, Publicly-Traded Company
- Workiva (WK) Tops Q1 EPS by 6c, Offers Guidance
- Inovalon (INOV) Misses Q1 EPS by 3c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!